NASDAQ:ORPN - Bioblast Pharma News Headlines

Sign in or create an account to add this stock to your watchlist.
$10.82 +0.10 (+0.93 %)
(As of 03/18/2019 04:00 PM ET)
Previous Close$10.72
Today's Range$9.78 - $11.07
52-Week Range$6.16 - $30.00
Volume11,900 shs
Average Volume31,575 shs
Market Capitalization$4.52 million
P/E RatioN/A
Dividend YieldN/A
Beta1.41

Headlines

Bioblast Pharma (NASDAQ ORPN) News Headlines

Source:
DateHeadline
Bioblast Announces Effectiveness of Eight to One Reverse SplitBioblast Announces Effectiveness of Eight to One Reverse Split
finance.yahoo.com - March 6 at 9:41 AM
BioBlast up 64% on Trehalose deal with SeelosBioBlast up 64% on Trehalose deal with Seelos
seekingalpha.com - February 19 at 5:57 PM
Bioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos TherapeuticsBioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos Therapeutics
finance.yahoo.com - February 19 at 9:54 AM
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast PharmaSeelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
finance.yahoo.com - February 19 at 9:54 AM
4 Healthcare Stocks Looking to Start Strong on Tuesday (2/19/19)4 Healthcare Stocks Looking to Start Strong on Tuesday (2/19/19)
finance.yahoo.com - February 19 at 9:54 AM
Bioblast Pharma Announces Collaboration with Team Sanfilippo to Evaluate Trehalose for the Treatment of Sanfilippo SyndromeBioblast Pharma Announces Collaboration with Team Sanfilippo to Evaluate Trehalose for the Treatment of Sanfilippo Syndrome
finance.yahoo.com - February 15 at 10:01 AM
Bioblast Pharma receives Nasdaq deficiency noticeBioblast Pharma receives Nasdaq deficiency notice
seekingalpha.com - January 11 at 5:38 PM
Bioblast Pharma Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Non-ComplianceBioblast Pharma Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Non-Compliance
finance.yahoo.com - January 11 at 5:38 PM
BioBlast Pharma Ltd (ORPN) CEO Dalia Megiddo on Merger Agreement to Acquire Enlivex Therapeutics Conference Call (Transcript)BioBlast Pharma Ltd (ORPN) CEO Dalia Megiddo on Merger Agreement to Acquire Enlivex Therapeutics Conference Call (Transcript)
seekingalpha.com - November 21 at 9:08 AM
New Healthcare Trends Have Investors Looking at 4 StocksNew Healthcare Trends Have Investors Looking at 4 Stocks
finance.yahoo.com - November 20 at 4:35 PM
BioBlast to acquire Enlivex Therapeutics in all-stock dealBioBlast to acquire Enlivex Therapeutics in all-stock deal
seekingalpha.com - November 20 at 9:09 AM
BioBlast Pharma (ORPN) to Acquire Enlivex TherapeuticsBioBlast Pharma (ORPN) to Acquire Enlivex Therapeutics
www.streetinsider.com - November 20 at 9:09 AM
Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid TumorsBioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid Tumors
finance.yahoo.com - November 19 at 4:32 PM
Bioblast Pharma up 21%Bioblast Pharma up 21%
seekingalpha.com - October 4 at 4:18 PM
Bioblast Pharma Ltd. Corporate and Management UpdateBioblast Pharma Ltd. Corporate and Management Update
finance.yahoo.com - July 26 at 4:42 PM
Who Are The Top Investors In Bioblast Pharma Ltd (NASDAQ:ORPN)?Who Are The Top Investors In Bioblast Pharma Ltd (NASDAQ:ORPN)?
finance.yahoo.com - May 25 at 9:21 AM
Bioblast Pharma up 33%Bioblast Pharma up 33%
seekingalpha.com - May 18 at 11:17 AM
What Kind Of Risk Should You Expect For Bioblast Pharma Ltd (NASDAQ:ORPN)?What Kind Of Risk Should You Expect For Bioblast Pharma Ltd (NASDAQ:ORPN)?
finance.yahoo.com - April 10 at 4:28 PM
Should You Be Concerned About Bioblast Pharma Ltd’s (NASDAQ:ORPN) Investors?Should You Be Concerned About Bioblast Pharma Ltd’s (NASDAQ:ORPN) Investors?
finance.yahoo.com - February 22 at 4:51 PM
ICYMI: Shutterfly Downgrade, BioBlast Price Action, Blockchain ETFs - BenzingaICYMI: Shutterfly Downgrade, BioBlast Price Action, Blockchain ETFs - Benzinga
www.benzinga.com - January 18 at 4:10 PM
BioBlast CEO Calls Price Spike BizarreBioBlast CEO Calls Price Spike 'Bizarre'
www.benzinga.com - January 18 at 11:13 AM
Bioblast Pharma Reports Third Quarter 2017 Financial Results - GlobeNewswire (press release)Bioblast Pharma Reports Third Quarter 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - November 4 at 8:36 AM
Bioblast Pharma Reports Third Quarter 2017 Financial ResultsBioblast Pharma Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 4 at 8:36 AM
Bio Blast reports 3Q lossBio Blast reports 3Q loss
finance.yahoo.com - November 4 at 8:36 AM
Should You Invest In The Healthcare Stock Bioblast Pharma Ltd (ORPN)?Should You Invest In The Healthcare Stock Bioblast Pharma Ltd (ORPN)?
finance.yahoo.com - November 4 at 8:36 AM
Bioblast Announces Effectiveness of Five to One Reverse SplitBioblast Announces Effectiveness of Five to One Reverse Split
finance.yahoo.com - October 2 at 9:20 PM
Bioblast Pharma Reports Second Quarter 2017 Financial ResultsBioblast Pharma Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 5 at 5:38 AM
Bio Blast reports 2Q lossBio Blast reports 2Q loss
finance.yahoo.com - August 5 at 5:38 AM
BioBlast Pharma (ORPN) to Seek Strategic Alternatives Including Partnership or Merger - StreetInsider.comBioBlast Pharma (ORPN) to Seek Strategic Alternatives Including Partnership or Merger - StreetInsider.com
www.streetinsider.com - June 6 at 8:24 AM
Bioblast Pharma Reports First Quarter 2017 Financial Results - GlobeNewswire (press release)Bioblast Pharma Reports First Quarter 2017 Financial Results - GlobeNewswire (press release)
www.globenewswire.com - May 28 at 5:26 AM
Bioblast Pharma Reports First Quarter 2017 Financial Results - NasdaqBioblast Pharma Reports First Quarter 2017 Financial Results - Nasdaq
www.nasdaq.com - May 26 at 8:14 PM
Bioblast Pharma Announces Plans in Response to Nasdaq Notifications Regarding Stockholders Equity and Minimum ... - NasdaqBioblast Pharma Announces Plans in Response to Nasdaq Notifications Regarding Stockholders' Equity and Minimum ... - Nasdaq
www.nasdaq.com - April 20 at 12:08 AM
Bioblast Pharma Announces Receipt of Nasdaq Notification Regarding Stockholders’ EquityBioblast Pharma Announces Receipt of Nasdaq Notification Regarding Stockholders’ Equity
us.rd.yahoo.com - March 10 at 8:52 PM
Bioblast Pharma Reports Fourth Quarter and Year End 2016 Financial ResultsBioblast Pharma Reports Fourth Quarter and Year End 2016 Financial Results
us.rd.yahoo.com - February 24 at 8:45 AM
Bioblast Pharma Provides Clinical and Development Updates on Trehalose as a Potential Therapeutic for OPMD and Other Neurodegenerative DiseasesBioblast Pharma Provides Clinical and Development Updates on Trehalose as a Potential Therapeutic for OPMD and Other Neurodegenerative Diseases
us.rd.yahoo.com - February 2 at 7:59 PM
4:02 pm Bio Blast Pharma announces clinical update related to its proprietary intravenous (:IV) form of trehalose 90 mg/mL solution, which is being evaluated as a potential therapeutic, initially for oculopharyngeal muscular dystrophy4:02 pm Bio Blast Pharma announces clinical update related to its proprietary intravenous (:IV) form of trehalose 90 mg/mL solution, which is being evaluated as a potential therapeutic, initially for oculopharyngeal muscular dystrophy
us.rd.yahoo.com - February 2 at 7:59 PM
This page was last updated on 3/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel